Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-04-03 Sale | 2023-04-05 8:30 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 11,654 | $29.63 | $345,334 | 1,220,979 (Indirect Direct) | View |
2023-04-03 Sale | 2023-04-05 8:30 pm | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO | 3,672 | $29.73 | $109,164 | 112,290 (Direct) | View |
2023-04-03 Sale | 2023-04-05 8:30 pm | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 2,092 | $29.63 | $61,996 | 82,790 (Direct) | View |
2023-04-03 Sale | 2023-04-05 8:30 pm | Beam Therapeutics Inc. | BEAM | Simon Amy Chief Medical Officer | 16,099 | $29.87 | $480,843 | 69,308 (Direct) | View |
2023-04-03 Sale | 2023-04-05 8:30 pm | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 4,640 | $29.74 | $137,978 | 47,117 (Direct) | View |
2023-01-26 Sale | 2023-01-30 4:05 pm | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 37,254 | $45.08 | $1,679,510 | 438,559 (Direct) | View |
2023-01-23 Sale | 2023-01-25 5:25 pm | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 20,236 | $45.02 | $910,947 | 491,725 (Direct) | View |
2023-01-18 Sale | 2023-01-20 4:18 pm | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 47,195 | $45.14 | $2,130,382 | 274,332 (Direct) | View |
2023-01-03 Sale | 2023-01-05 4:06 pm | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO | 53,729 | $37.46 | $2,012,490 | 246,867 (Direct) | View |
2022-12-12 Sale | 2022-12-14 9:50 pm | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO | 51,015 | $42.7 | $2,178,229 | 285,279 (Direct) | View |
2022-10-31 Sale | 2022-11-02 4:30 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 50,000 | $46.33 | $2,316,428 | 1,161,520 (Indirect Direct) | View |
2022-09-06 Sale | 2022-09-08 11:04 am | Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner | 551 | $54.25 | $29,892 | 4,964,709 (Indirect) | View |
2022-08-05 Sale | 2022-08-08 4:49 pm | Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner | 20,326 | $60.5 | $1,229,807 | 2,231,506 (Indirect) | View |
2022-07-28 Sale | 2022-07-29 4:06 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 50,000 | $65.76 | $3,288,081 | 1,211,520 (Indirect Direct) | View |
2022-04-28 Sale | 2022-05-02 6:51 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 50,000 | $37.98 | $1,898,899 | 1,709,415 (Indirect Direct) | View |
2022-04-13 Sale | 2022-04-14 5:13 pm | Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner | 19,466 | $50.41 | $981,205 | 2,701,029 (Indirect) | View |
2022-03-31 Sale | 2022-04-04 8:32 pm | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO | 1,859 | $59.11 | $109,885 | 115,614 (Direct) | View |
2022-03-31 Sale | 2022-04-04 8:27 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 6,261 | $59.11 | $370,088 | 1,252,070 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-06-06 Option Award | 2023-06-08 5:02 pm | N/A 2033-06-06 | Beam Therapeutics Inc. | BEAM | Burow Kristina Director | 16,532 | $0 | 5,485,582 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 4:56 pm | N/A 2033-06-06 | Beam Therapeutics Inc. | BEAM | COOPER GRAHAM K Director | 16,532 | $0 | 16,532 (Direct) | View |
2033-06-06 Option Award | 2023-06-08 4:52 pm | N/A 2023-06-06 | Beam Therapeutics Inc. | BEAM | Walsh Kathleen E Director | 16,532 | $0 | 16,532 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 4:51 pm | N/A 2033-06-06 | Beam Therapeutics Inc. | BEAM | Fishman Mark Director | 16,532 | $0 | 16,532 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 4:49 pm | N/A 2033-06-06 | Beam Therapeutics Inc. | BEAM | Ho Carole Director | 16,532 | $0 | 16,532 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 4:47 pm | N/A 2033-06-06 | Beam Therapeutics Inc. | BEAM | MARAGANORE JOHN Director | 16,532 | $0 | 16,532 (Direct) | View |
2023-01-31 Option Award(A) | 2023-04-19 4:30 pm | N/A 2033-01-31 | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 40,000 | $0 | 40,000 (Direct) | View |
2023-03-30 Exercise | 2023-03-31 7:51 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 8,941 | $7.22 | 115,292 (Direct) | View |
2023-03-31 Option Award | 2023-03-31 7:51 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 17,500 | $0 | 115,292 (Direct) | View |
2023-03-30 Exercise | 2023-03-31 7:51 pm | N/A 2029-05-16 | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 8,941 | $0 | 115,292 (Direct) | View |
2023-01-31 Option Award | 2023-03-31 7:49 pm | N/A 2033-01-31 | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO | 60,000 | $0 | 155,962 (Direct) | View |
2023-03-31 Exercise | 2023-03-31 7:48 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 13,850 | $7.22 | 1,541,557 (Direct) | View |
2023-01-31 Option Award | 2023-03-31 7:48 pm | N/A 2033-01-31 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 168,750 | $0 | 1,541,557 (Direct) | View |
2023-03-31 Exercise | 2023-03-31 7:48 pm | N/A 2029-05-17 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 13,850 | $0 | 1,541,557 (Direct) | View |
2023-03-06 Acquisition | 2023-03-31 7:48 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 225 | $0 | 1,541,557 (Direct) | View |
2023-03-31 Option Award | 2023-03-31 7:47 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Simon Amy Chief Medical Officer | 20,000 | $0 | 85,129 (Direct) | View |
2023-01-31 Option Award | 2023-03-31 7:46 pm | N/A 2033-01-31 | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 40,000 | $0 | 71,277 (Direct) | View |
Ownership | 2023-03-27 6:23 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Simon Amy Chief Medical Officer | 0 | $0 | 224,629 (Direct) | View |
Ownership | 2023-03-27 6:22 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 0 | $0 | 221,751 (Direct) | View |
2023-01-26 Exercise | 2023-01-30 4:05 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 37,254 | $13.68 | 438,559 (Direct) | View |
2023-01-26 Exercise | 2023-01-30 4:05 pm | N/A 2029-08-31 | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 37,254 | $0 | 438,559 (Direct) | View |
2023-01-23 Exercise | 2023-01-25 5:25 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 20,236 | $13.68 | 491,725 (Direct) | View |
2023-01-23 Exercise | 2023-01-25 5:25 pm | N/A 2029-08-31 | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 20,236 | $0 | 491,725 (Direct) | View |
2023-01-18 Exercise | 2023-01-20 4:18 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 39,886 | $13.68 | 274,332 (Direct) | View |
2023-01-18 Exercise | 2023-01-20 4:18 pm | N/A 2029-08-31 | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 39,886 | $0 | 274,332 (Direct) | View |
2023-01-03 Exercise | 2023-01-05 4:06 pm | N/A 2028-05-08 | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO | 53,729 | $0 | 246,867 (Direct) | View |
2023-01-03 Exercise | 2023-01-05 4:06 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO | 4,326 | $4.22 | 246,867 (Direct) | View |
2023-01-03 Exercise | 2023-01-05 4:06 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO | 49,403 | $0.67 | 246,867 (Direct) | View |
2022-12-30 Exercise | 2023-01-03 4:31 pm | N/A 2028-05-08 | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO | 4,500 | $0 | 287,164 (Direct) | View |
2022-12-30 Exercise | 2023-01-03 4:31 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO | 4,500 | $0.67 | 287,164 (Direct) | View |
2022-12-12 Exercise(A) | 2022-12-20 4:05 pm | N/A 2028-05-08 | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO | 18,211 | $0 | 9,106 (Direct) | View |
2022-12-12 Exercise | 2022-12-14 9:50 pm | N/A 2028-05-08 | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO | 26,863 | $0 | 285,279 (Direct) | View |
2022-12-12 Exercise | 2022-12-14 9:50 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO | 8,652 | $4.22 | 285,279 (Direct) | View |
2022-12-12 Exercise | 2022-12-14 9:50 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO | 18,211 | $0.67 | 285,279 (Direct) | View |
2022-09-06 Other | 2022-09-08 11:04 am | N/A N/A | Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner | 26,171 | $0 | 4,964,709 (Indirect) | View |
2022-09-01 Option Award | 2022-09-02 4:06 pm | N/A 2032-09-01 | Beam Therapeutics Inc. | BEAM | Burow Kristina Director | 10,391 | $0 | 10,391 (Direct) | View |
2022-09-01 Option Award | 2022-09-02 4:05 pm | N/A 2032-09-01 | Beam Therapeutics Inc. | BEAM | Ho Carole Director | 10,391 | $0 | 10,391 (Direct) | View |
2022-09-01 Option Award | 2022-09-02 4:05 pm | N/A 2032-09-01 | Beam Therapeutics Inc. | BEAM | MARAGANORE JOHN Director | 10,391 | $0 | 10,391 (Direct) | View |
2022-09-01 Option Award | 2022-09-02 4:05 pm | N/A 2032-09-01 | Beam Therapeutics Inc. | BEAM | COOPER GRAHAM K Director | 10,391 | $0 | 10,391 (Direct) | View |
2022-09-01 Option Award | 2022-09-02 4:05 pm | N/A 2032-09-01 | Beam Therapeutics Inc. | BEAM | Walsh Kathleen E Director | 10,391 | $0 | 10,391 (Direct) | View |
2022-09-01 Option Award | 2022-09-02 4:05 pm | N/A 2032-09-01 | Beam Therapeutics Inc. | BEAM | Fishman Mark Director | 10,391 | $0 | 10,391 (Direct) | View |
2022-08-04 Other | 2022-08-08 4:49 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner | 2,231,506 | $0 | 2,231,506 (Indirect) | View |
2022-04-28 Exercise | 2022-05-02 6:51 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 47,204 | $1.03 | 1,709,415 (Direct) | View |
2022-04-28 Exercise | 2022-05-02 6:51 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 12,246 | $7.22 | 1,709,415 (Direct) | View |
2022-04-28 Exercise | 2022-05-02 6:51 pm | N/A 2029-05-17 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 59,450 | $0 | 1,709,415 (Direct) | View |
2022-04-12 Other | 2022-04-14 5:13 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner | 2,701,029 | $0 | 2,701,029 (Indirect) | View |
2022-03-31 Option Award | 2022-04-04 8:32 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO | 15,000 | $0 | 115,614 (Direct) | View |
2022-03-31 Option Award | 2022-04-04 8:27 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 56,250 | $0 | 1,252,070 (Direct) | View |